Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE

BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

Standard Dose
5MG;6.25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 219489 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 5MG;6.25MG Sponsor UNIQUE PHARM Submission history Latest submission status date: 2026-03-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 219489 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 5MG;6.25MG Sponsor UNIQUE PHARM Submission history Latest submission status date: 2026-03-24 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE) | Drug Monograph | MedicHelpline